Suicide Risk 30 Days After a Potentially Traumatic Event in Patients Treated by a Medico-psychological Emergency Unit
SCAR
Suicide Risk Within 30 Days After a Potentially Traumatic Event (PTE) in Patients Treated by a Medico-psychological Emergency Unit. Prospective Cohort Study
1 other identifier
observational
240
1 country
4
Brief Summary
The national french survey "Mental health in general population", showed that the risk of suicide was significantly increased during exposure to a potentially traumatic event (PTE), with an increasing gradient depending on the psychological impact. This included not only people suffering from post-traumatic stress disorder but also those confronted with PTE, presenting or having presented phenomena of reviviscence or at least an element of psychopathological impact. This risk could concern 30.2% of the population over the entire lifetime. Internationally, recent reviews of the literature tend to show that victims of interpersonal violence are more at risk of suicide (OR 1.99 95% CI: 1.73-2.28). Nevertheless, the literature remains heterogeneous, the definitions vague and the temporal proximity of the violence little taken into account. It is therefore a large-scale phenomenon that remains little explored. To increase our knowledge in this area, the investigators will focus on patients treated by Emergency Medical Psychological Cells (CUMP), that is victims of disasters, accidents involving a large number of victims or events that may have significant psychological repercussions due to the circumstances surrounding them.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2022
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 18, 2021
CompletedFirst Posted
Study publicly available on registry
May 24, 2021
CompletedStudy Start
First participant enrolled
September 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2024
CompletedMay 27, 2022
May 1, 2022
12 months
May 18, 2021
May 23, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Suicidal risk
Absence or presence of the suicidal risk assessed using the French transcultural adaptation of the Mini-International Neuropsychiatric Interview (MINI) after the possible psychological trauma
30 days
Secondary Outcomes (14)
Depressive disorders
30 days
Bipolar disorders
30 days
Panic disorder
30 days
Agoraphobia
30 days
Social phobia
30 days
- +9 more secondary outcomes
Eligibility Criteria
Patients fulfilling the inclusion and non-inclusion criteria and having signed the consent will be included. Within 30 days (± 5 days), an appointment, by videoconference, will be made by the CUMP of the Grenoble center for the completion of the MINI scale and screening for suicidal behavior. This interview will be carried out either with the psychiatrist or the psychologist or with the psychiatric resident. If the patient does not answer, the trusted third party or the attending physician will be contacted by telephone in order to investigate the causes or to detect a possible death by suicide. The patient will be followed up one year after inclusion by telephone to detect the number of suicide attempts and/or death.
You may qualify if:
- Patient treated for the first time by a CUMP directly confronted with a potentially traumatic event (PTE) (with ou without a previous psychiatric history)
- Patient affiliated with social welfare
You may not qualify if:
- Age under 18
- Not understanding French language.
- Not having provided the contact details of a trusted third party and of the attending physician
- Being homeless
- Information on the exhibition unavailable (subjects recently arrived in France, foreign language, etc.)
- A pathology requiring urgent medical treatment
- Covered by articles L1121-5 to L1121-8 of the CSP (pregnant women, parturients, breastfeeding women, persons deprived of their liberty by a judicial or administrative decision, persons undergoing psychiatric care and adults subject to a measure of legal protection or unable to express their consent).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
DELACHENAL Catherine
Chambéry, France
Geneste-Saelens
Clermont-Ferrand, France
VIGNAUD Philippe
Lyon, France
COURVOISIER Pierre
Montéléger, France
Study Officials
- PRINCIPAL INVESTIGATOR
Helene Poncet, MD
CHU Grenoble Alpes, SAMU38 - CUMP
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 18, 2021
First Posted
May 24, 2021
Study Start
September 1, 2022
Primary Completion
August 30, 2023
Study Completion
April 30, 2024
Last Updated
May 27, 2022
Record last verified: 2022-05